Activation of neutral sphingomyelinase participates in ethanol-induced apoptosis in Hep G2 cells.
- Authors
- Liu, J J; Wang, J Y; Hertervig, E; Cheng, Y; Nilsson, A; Duan, R D
- Year
- 2000
- Journal
- Alcohol and alcoholism (Oxford, Oxfordshire)
- PMID
- 11093963
- DOI
- 10.1093/alcalc/35.6.569
The mechanism underlying ethanol-induced apoptosis in liver cells is not clear. Sphingomyelin (SM) metabolism is a novel signal transduction pathway that has an impact on apoptosis in many cell types. We investigated whether the SM pathway is involved in ethanol-induced apoptosis in the liver. Hep G2 cells were treated with ethanol followed by assaying apoptosis, sphingomyelinase (SMase) activity, caspase-3 activity, and the changes of SM content in the cells. We found that ethanol dose-dependently increased apoptosis and the effect was accompanied by increases of caspase-3 activity and neutral SMase activity. At concentrations of 80 and 160 mM, ethanol significantly increased caspase-3 activity by 120% and neutral SMase activity by 24%. The activity of acid SMase was only slightly increased without statistical significance. C(2)-ceramide, the exogenous SM metabolite, mimicked the effects of ethanol on apoptosis and caspase-3 activation. When the SM content was determined 24 h after treatment with ethanol, its level was 15% lower than that of controls. The results indicate that metabolism of SM triggered by neutral SMase participates in ethanol-induced apoptosis in Hep G2 cells and activation of caspase-3 is involved in the apoptotic pathway.
No figures extracted from this document.
No chunks — full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Allele-specific expression and high-throughput reporter assay reveal functional genetic variants associated with alcohol use disorders. | 2021 | 31477794 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Metabolic Signature of Ethanol-Induced Hepatotoxicity in HepaRG Cells by Liquid Chromatography-Mass Spectrometry-Based Untargeted Metabolomics. | Iturrospe E et al. | — | 2022 | → |
| Allele-specific expression and high-throughput reporter assay reveal functional genetic variants associated with alcohol use disorders. | Rao X et al. | — | 2021 | → |
| The Association between Alcohol Consumption and Serum Metabolites and the Modifying Effect of Smoking. | Langenau J et al. | — | 2019 | → |
| Are Metabolic Signatures Mediating the Relationship between Lifestyle Factors and Hepatocellular Carcinoma Risk? Results from a Nested Case-Control Study in EPIC. | Assi N et al. | — | 2018 | → |
| Ceramide and Its Related Neurochemical Networks as Targets for Some Brain Disorder Therapies. | Brodowicz J et al. | — | 2018 | → |
| Circulating Metabolites Associated with Alcohol Intake in the European Prospective Investigation into Cancer and Nutrition Cohort. | van Roekel EH et al. | — | 2018 | → |
| Lipidomic signature of serum from the rats exposed to alcohol for one year. | Li H et al. | — | 2018 | → |
| Peripheral Acid Sphingomyelinase Activity Is Associated with Biomarkers and Phenotypes of Alcohol Use and Dependence in Patients and Healthy Controls. | Mühle C et al. | — | 2018 | → |
| Cardiovascular Risk Factors Associated With Blood Metabolite Concentrations and Their Alterations During a 4-Year Period in a Population-Based Cohort. | Lacruz ME et al. | — | 2016 | → |
| Alterations of plasma glycerophospholipid and sphingolipid species in male alcohol-dependent patients. | Reichel M et al. | — | 2015 | → |
| Sphingolipids: key regulators of apoptosis and pivotal players in cancer drug resistance. | Giussani P et al. | — | 2014 | → |
| Alcohol-induced metabolomic differences in humans. | Jaremek M et al. | — | 2013 | → |
| Ceramide function in the brain: when a slight tilt is enough. | Mencarelli C et al. | — | 2013 | → |
| Sphingolipids in psychiatric disorders and pain syndromes. | Mühle C et al. | — | 2013 | → |
| Activity of secretory sphingomyelinase is increased in plasma of alcohol-dependent patients. | Reichel M et al. | — | 2011 | → |
| Altered hepatic lipid metabolism in C57BL/6 mice fed alcohol: a targeted lipidomic and gene expression study. | Clugston RD et al. | — | 2011 | → |
| Increased acid sphingomyelinase activity in peripheral blood cells of acutely intoxicated patients with alcohol dependence. | Reichel M et al. | — | 2010 | → |
| Effects of ethanol and lipopolysaccharide on the sphingomyelin cycle in rat hepatocytes. | Viktorov AV et al. | — | 2008 | → |
| Effects of flavonoids on sphingolipid turnover in the toxin-damaged liver and liver cells. | Babenko NA et al. | — | 2008 | → |
| The mechanism of elevated toxicity in HepG2 cells due to combined exposure to ethanol and ionizing radiation. | Ogony J et al. | — | 2008 | → |
| Vitamin E succinate induces ceramide-mediated apoptosis in head and neck squamous cell carcinoma in vitro and in vivo. | Gu X et al. | — | 2008 | → |
| Sphingolipids and cell death. | Morales A et al. | — | 2007 | → |
| Ethanol-induced changes in the content of triglycerides, ceramides, and glucosylceramides in cultured neurons. | Saito M et al. | — | 2005 | → |
| Acid and neutral sphingomyelinases: roles and mechanisms of regulation. | Marchesini N et al. | — | 2004 | → |
| Biologically active sphingolipids in cancer pathogenesis and treatment. | Ogretmen B et al. | — | 2004 | → |
| Betaine decreases hyperhomocysteinemia, endoplasmic reticulum stress, and liver injury in alcohol-fed mice. | Ji C et al. | — | 2003 | → |
| Ceramide pathways modulate ethanol-induced cell death in astrocytes. | Pascual M et al. | — | 2003 | → |
| Designing anticancer drugs via the achilles heel: ceramide, allylic ketones, and mitochondria. | Radin NS | — | 2003 | → |